[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359421-105":59,"doc-detail-359421-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","influence-of-usp15-and-its-derived-peptide-on-non-small-cell-lung-cancer-immune-evasion-via-regulating-pd-l1-stability","Influence of USP15 and its derived-peptide on non-small cell lung cancer immune evasion via regulating PD-L1 stability","","Immune checkpoint inhibitors targeting PD-1/PD-L1 show clinical promise in non-small cell lung cancer (NSCLC), yet low response rates and acquired resistance require clearer regulatory mechanisms of PD-L1 expression. This study investigates ubiquitin-specific protease 15 (USP15) and its derived peptide U10, focusing on how they drive NSCLC immune evasion through PD-L1 stability regulation. USP15 was identified as a PD-L1 deubiquitinase, binds and stabilizes PD-L1, and promotes CD8+ T-cell reduction and impaired tumor killing.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/influence-of-usp15-and-its-derived-peptide-on-non-small-cell-lung-cancer-immune-evasion-via-regulating-pd-l1-stability/359421/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/influence-of-usp15-and-its-derived-peptide-on-non-small-cell-lung-cancer-immune-evasion-via-regulating-pd-l1-stability/359421.png","ImageObject",300,407,{"name":92,"@type":93},"Connor ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on USP15 and NSCLC?","Question",{"text":112,"@type":113},"To determine how USP15 and its derived peptide U10 influence NSCLC immune evasion by regulating PD-L1 stability and thereby affecting PD-1/PD-L1 immune checkpoint activity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does USP15 affect PD-L1 in NSCLC cells?",{"text":117,"@type":113},"USP15 functions as a deubiquitinase of PD-L1, binding and stabilizing PD-L1 by inhibiting its ubiquitination and degradation.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the therapeutic potential of the USP15-derived peptide U10?",{"text":121,"@type":113},"U10 is designed to disrupt the USP15–PD-L1 interaction, promote PD-L1 degradation, suppress NSCLC immune escape in vitro and in mice, and enhance the anti-NSCLC effect of PD-1 monoclonal antibody in mice.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359421,1790211605,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Open access Original research  \n Influence of USP15 and its derived  \npeptide on non-small cell lung cancer immune evasion via regulating PDL1 stability  \nDi Wu  ,1,2,3 Ting Zeng  ,1,2,3 Ruo-Huang Lu  ,4 Wei Zhu  ,1,3 Qi Wen  ,2,3 Xue-Li Mao  ,2,3 Zheng-Zheng Yu  ,2,3 Guo-Xiang Lin  ,2,3 Yun-Xi Peng  ,2,3 Shan-Shan Lu  ,2,3 Hong Yi  ,2,3 Wei Huang  ,2,3 Zhi-Qiang Xiao  ,1,2,3 Jinwu Peng  1,2,3  \nTo cite: Wu D, Zeng T, Lu RH, et al. Influence of USP15 and its derived-peptide on non-small cell lung cancer immune evasion via regulating PD-L1 stability. Journal for ImmunoTherapy of Cancer 2026;14:e014233 . doi:10 . 1136/ jitc-2025-014233  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2025-014233](jitc-2025-014233)) .  \nDW and TZ contributed equally. Accepted 13 March 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nProfessor Zhi-Qiang Xiao; [zhiqiangxiao@csu.edu.cn](zhiqiangxiao@csu.edu.cn)  \nProfessor Jinwu Peng; [jinwupeng@csu.edu.cn](jinwupeng@csu.edu.cn)  \nABSTRACT  \nBackground Immune checkpoint inhibitors (ICIs) therapy targeting programmed cell death protein 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) shows promising clinical benefits in non-small cell lung cancer (NSCLC) . However, the relatively low response rate highlights the need to elucidate the regulatory mechanism of PD-L1 expression, and develop an alternative strategy to target PD-1/PD-L1 immune checkpoint pathway. Our study focuses on the role and mechanism of ubiquitinspecific protease 15 (USP15) and its derived peptide U10 on NSCLC immune evasion.  \nMethods USP15 as PD-L1’s deubiquitinase was identified by screening a human USP complementary DNA (cDNA) library. The role and mechanism of USP15 and its derived peptide U10 on PD-L1 stability in NSCLC cells were analyzed. T cell-mediated tumor cell killing activity anda syngeneic mouse NSCLC model were used to assess the influence of USP15 and U10 on NSCLC immune evasion. The antitumor effect of U10 in combination with PD-1 monoclonal antibody (mAb) via suppressing NSCLC immune evasion was also evaluated in mice. The expression and clinicopathological significance of USP15 and PD-L1 in cancer tissues were evaluated by immunohistochemistry.  \nResults We identify USP15 as a novel deubiquitinase of PD-L1 . Mechanistically, USP15 binds and stabilizes PD-L1 in NSCLC cells by inhibiting its ubiquitination and degradation. Functionally, USP15 inhibits T cell ability of killing NSCLC cells in vitro, and promotes NSCLC immune evasion in mice via decreasing the population and activation of CD8+ T cells in the tumor microenvironment. Based on the interacting regions of USP15 and PD-L1, we develop a 10 amino acid-long USP15-derived peptide U10, which successfully degrades PD-L1 via disrupting USP15 and PD-L1 interaction, dramatically suppresses NSCLC immune escape in vitro and in mice, and enhances the anti-NSCLC effect of PD-1 mAb in mice. Moreover, the expression levels of USP15 and PD-L1 are significantly higher in NSCLC than those in normal lung tissues and are positively correlated. The combination of USP15 and PD-L1 proteins was superior to individual proteins for predicting the efficacy of PD-1 mAb immunotherapy and patient prognosis in NSCLC.  \nWHAT IS ALREADY KNOWN ON THIS TOPIC  \n\n| ⇒ Immune checkpoint inhibitors (ICIs) therapy targeting programmed cell death protein 1/programmed cell death-ligand 1 (PD-1/PD-L1) shows promising clinical benefits in non-small cell lung cancer (NSCLC) . However, the majority of individuals either fail to respond or eventually develop resistance to ICIs, highlighting the urgent need to elucidate the molecular mechanisms upregulating PD-L1 expression in NSCLC and to for","cbCaidUFcWVSWIBf","https://ap.wps.com/l/cbCaidUFcWVSWIBf","pdf",9108060,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## What is already known on this topic\n## What this study adds\n## How this study might affect research, practice or policy\n## Conclusion\n# Background","[{\"question\":\"What is the main goal of the study on USP15 and NSCLC?\",\"answer\":\"To determine how USP15 and its derived peptide U10 influence NSCLC immune evasion by regulating PD-L1 stability and thereby affecting PD-1/PD-L1 immune checkpoint activity.\"},{\"question\":\"How does USP15 affect PD-L1 in NSCLC cells?\",\"answer\":\"USP15 functions as a deubiquitinase of PD-L1, binding and stabilizing PD-L1 by inhibiting its ubiquitination and degradation.\"},{\"question\":\"What is the therapeutic potential of the USP15-derived peptide U10?\",\"answer\":\"U10 is designed to disrupt the USP15–PD-L1 interaction, promote PD-L1 degradation, suppress NSCLC immune escape in vitro and in mice, and enhance the anti-NSCLC effect of PD-1 monoclonal antibody in mice.\"}]","Influence of USP15 and its derived-peptide on non-small cell lung cancer immune evasion via regulating PD-L1 stability | PDF",1790136855,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e853b00473cd1839d97d99d867c61896.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/892c77b76a77abb8aacb9b29d2bf5ef8.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81b687fc3315231bd9fbfc8bd7b7b8f8.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79f40621275e6b075466c24e49dbd78b.webp",980,1306]